METTL3 mitigates age-related hearing loss by inhibiting NF-κB-mediated inflammatory responses through the m(6)A modification of NFKBIA.
- DOI
- 10.1007/s00109-026-02714-5
- Published
- 2026 Sep 18
- Container
- Journal of molecular medicine (Berlin, Germany)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00109-026-02714-5,
title = {METTL3 mitigates age-related hearing loss by inhibiting NF-κB-mediated inflammatory responses through the m(6)A modification of NFKBIA.},
author = {Tan J and Luo J and Li L and Chen D and Wang J and Ge C and Li P},
year = {2026},
journal = {Journal of molecular medicine (Berlin, Germany)},
doi = {10.1007/s00109-026-02714-5},
url = {https://doi.org/10.1007/s00109-026-02714-5}
}RIS
TY - JOUR TI - METTL3 mitigates age-related hearing loss by inhibiting NF-κB-mediated inflammatory responses through the m(6)A modification of NFKBIA. AU - Tan J AU - Luo J AU - Li L AU - Chen D AU - Wang J AU - Ge C AU - Li P PY - 2026 JO - Journal of molecular medicine (Berlin, Germany) DO - 10.1007/s00109-026-02714-5 UR - https://doi.org/10.1007/s00109-026-02714-5 ER -
APA
J, T., J, L., L, L., D, C., J, W., C, G., & P, L. (2026). METTL3 mitigates age-related hearing loss by inhibiting NF-κB-mediated inflammatory responses through the m(6)A modification of NFKBIA.. Journal of molecular medicine (Berlin, Germany). https://doi.org/10.1007/s00109-026-02714-5
Source records
- pubmed · retrieved 2026-09-27T00:19:46.391Z